Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) logo Bentham Science Publishers logo

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Related content
Volume 9, Number 2, June 2009

< previous issue | all issues | next issue >


Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds
pp. 113-131(19)
Authors: Montrone, Michele; Martorelli, Debora; Rosato, Antonio; Dolcetti, Riccardo

T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions
pp. 132-144(13)
Authors: Honscheid, Andrea; Rink, Lothar; Haase, Hajo

The AKT Axis as a Therapeutic Target in Autoimmune Diseases
pp. 145-150(6)
Authors: Wu, Tianfu; Mohan, Chandra

Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease
pp. 178-186(9)
Authors: Sergejeva, S.; Linden, A.

Inflammatory Bowel Disease and Celiac Disease: Overlaps in the Pathology and Genetics, and their Potential Drug Targets
pp. 199-218(20)
Authors: Festen, Eleonora A.M.; Szperl, Agata M.; Weersma, Rinse K.; Wijmenga, Cisca; Wapenaar, Martin C.

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page